Amlodipine

This page contains recent news articles, when available, and an overview of Amlodipine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

Amlodipine (when available)

Pharmacology and use:
Zolmitriptan is a selective 5-hydroxytryptamine receptor subtype agonist indicated for the acute treatment of migraine attacks with or without aura in adults. Zolmitriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine. Zolmitriptan is an agonist for a vascular 5-hydroxytryptamine receptor subtype (probably a member of the 5-HT_1D family) having only a weak affinity for 5-HT_1A, 5-HT_5A, and 5-HT₇ receptors and no significant affinity or pharmacological activity at 5-HT₂, 5-HT₃ or 5-HT₄ receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Zolmitriptan also activates 5-HT₁ receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Zolmitriptan in humans. For the acute treatment of adult migraine (with or without auras)

Mechanism Of Action:
Zolmitriptan binds with high affinity to human 5-HT_1B and 5-HT_1D receptors leading to cranial blood vessel constriction. Current theories proposed to explain the etiology of migraine headache suggest that symptoms are due to local cranial vasodilatation and/or to the release of sensory neuropeptides (vasoactive intestinal peptide, substance P and calcitonin gene-related peptide) through nerve endings in the trigeminal system. The therapeutic activity of zolmitriptan for the treatment of migraine headache can most likely be attributed to the agonist effects at the 5HT1B/1D receptors on intracranial blood vessels (including the arterio-venous anastomoses) and sensory nerves of the trigeminal system which result in cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release.

News Articles on Zolmitriptan

Glenmark arm gets nod from USFDA for Amlodipine Besylate  -  ‎Apr 16, 2009‎
Glenmark Pharma`s arm Glenmark Generics has received a final approval to market Amlodipine Besylate tablet in the strengths of EQ 2.5MG base, EQ 5MG base, Myiris.com

PILL UNDER PRESSURE - Local companies blocked from selling cheap ...  -  ‎Mar 29, 2009‎
But, two weeks ago, the Montego Bay-based Indies Pharma placed its generic drug Amlocor (amlodipine) on the market, sparking a legal battle with Pfizer-USA. Jamaica Gleaner

Takeda files NDA for fixed dose combination of hypertension drug  -  ‎Mar 31, 2009‎
Amlodipine besylate is a calcium channel blocker, having a hypotensive action by blocking inward calcium ion channels mainly in vascular smooth-muscle cells Trading Markets (press release)

Determining Reasonable Remuneration for In-Service Inventions  -  ‎Apr 7, 2009‎
...(1) Yu-sup Jung invented an amlodipine nicotinate formulation and method for preparing the same in 2002 while employed at Hanlim Pharmaceuticals. International Law Office

Indian market firm in early trade  -  ‎Apr 16, 2009‎
Glenmark Pharma is gaining 3.67% after its subsidiary Glenmark Generics received the final approval to market Amlodipine Besylate tablets from the USFDA. RTT News

Stocks to watch: DLF, Tech Mahindra, AREVA T&D...  -  ‎Apr 16, 2009‎
Glenmark Pharma`s arm Glenmark Generics has received a final approval to market Amlodipine Besylate Tablet in the strengths of EQ 2.5MG base, EQ 5MG base, Myiris.com

In the business of saving lives  -  ‎Apr 1, 2009‎
Dumo says, “Pfizer’s amlodipine besylate, a medication for hypertension, is definitely a product of well-developed research. The company spent 10 to 15 Philippine Star

Takeda seeks approval for hypertension combination therapy  -  ‎Mar 30, 2009‎
Takeda has applied to Japanese authorities for approval of Blopress combined with amlodipine besylate as a treatment for hypertension. Hays Pharma

Dr Kamal K Sharma, MD, Lupin Ltd  -  ‎Mar 31, 2009‎
The recently launched Amlodipine ‘Amel’ continues to maintain majority market share and Risperidone ‘Amel’, which was launched last year, remains market India Infoline.com

Native medicines·improved new drugs boosted growth  -  ‎Apr 1, 2009‎
...‘Amodipine’ (Hanmi Pharm), an improved new generic version of amlodipine, which created the craze for the production of improved new versions, 디지틀보사

Persistent Chest Pain and No Obstructive Coronary Artery Disease  -  ‎Apr 7, 2009‎
Lanza GA, Colonna G, Pasceri V, Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol. Journal of American Medical Association (subscription)

혈압강하제 등 �?�약품 120개 15�?�부터 신규 보험등재  -  ‎Apr 5, 2009‎
...한국화�?��?제약�?� ‘노바스�?�정10mg(amlodipine)’ 등 �? 16개가 추가�??다. 소화성궤양용제 목�?�?는 태�?�양제약�?� 가스렌정(artemisia asiatica 95% ethanol ext. 헬스코리아뉴스

09年执业西�?�师�?�物化  -  ‎Apr 16, 2009‎
...为第一代钙拮抗剂；第二代钙拮抗剂扩张冠状动脉作用更强，作用维�?时间长，例如尼�?�地平（Nicardipine）�?尼群地平（Nitrendipine）�?氨氯地平（Amlodipine）等。青年人

09年执业西�?�师�?��?�学辅导：第二�??一章第三节常用钙拮抗�?�  -  ‎Apr 15, 2009‎
...氨氯地平（amlodipine）舒张冠脉�?�外周血管，用于治疗中�?轻度高血压作用缓慢�?久，�?低血压10%～18%，无�??射性心动过速。治疗稳定型心绞痛效果明显。青年人

金�?�?�机下的全�?�制�?��?业研�?�现状分�?  -  ‎Apr 14, 2009‎
...领域的早期研�?�工作(辉瑞凭借�?�阿托�?他汀(atorvastatin，Lipitor)与苯磺酸氨氯地平(amlodipine besylate，Norvasc)在该治疗领域的市场上一直�?��?��?�主导地�?)。中国生物技术信息网

Letters to New England Journal of Medicine question details about ...  -  ‎Mar 11, 2009‎
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-28. Davis BR, Whelton PK. TheHeart.Org

Class: Calcium channel blocker  -  ‎Mar 5, 2009‎
Amlodipine is the drug of choice for treatment of Raynaud’s disease in adults. Controls blood pressure, maintains kidney function, and reduces rejection EMS1.com - Emergency Medical Service Resources

Am I heading towards kidney failure?  -  ‎Mar 14, 2009‎
Q. I am 35 years old and was diagnosed with hypertension (180/120 mmHg) and put on Amlodipine. Doctor suspected secondary hypertension and did a series of NDTV.com

Growth in Health Care Spending Slows, But Still Outpaces Rate of ...  -  ‎Feb 24, 2009‎
In 2007, amlodipine besylate, amlodipine and benazepril, carvedilol, metoprolol succinate, and zolpidem lost patent exclusivity. The 7.3% hospital spending Journal of American Medical Association (subscription)

Erosive lesions on the hand  -  ‎Mar 12, 2009‎
She had not been compliant with her dialysis regimen or her medications: darbepoetin alfa (Aranesp), ferrous sulfate, atorvastatin (Lipitor), and amlodipine Clinical Advisor

New Trial Data, Guidelines, and Epidemiology of Stress ...  -  ‎Mar 4, 2009‎
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417-2428. Abstract Jamerson KA, Weber MA, Medscape

CEO likes to combine science, sales  -  ‎Mar 6, 2009‎
We combined our product Benicar, as it's known in the United States, with amlodipine, which is a different class of anti-hypertensive, into what we call a Trading Markets (press release)

Single bid for Lipitor · Cozaar…competition for domestic companies  -  ‎Mar 8, 2009‎
Besides, in the case of Amlodipine drugs, ‘Novarsc’ of Pfizer was designated as a single item, while Dong-a, Hanmi, CJ, Chong Kun Dang, and SK have to 디지틀보사

High blood pressure in pets reason for concern  -  ‎Feb 21, 2009‎
Mild risk is a value of 150-159 mm-Hg, moderate risk is a value of 160-179 mm-Hg, and severe risk is greater than 180 mm-Hg. Amlodipine or Norvasc is the Stockton Record

Office management of patients with diastolic heart failure  -  ‎Mar 4, 2009‎
She has a history of hypertension, which is being treated with amlodipine. On her initial visit 2 months previously, you prescribed furosemide 40 mg once CMAJ

Pfizer generics chief eyes licensing, injectables  -  ‎Feb 27, 2009‎
Where if you get into how many people are selling (Pfizer's off-patent blood-pressure pill) amlodipine in this country you have to go to all your fingers Reuters

약가�?�하 �?향…�?�약품 가중�?�균값 하�?�  -  ‎Mar 4, 2009‎
...를 보였다. amlodipine besylate 6.944mg성분�?� 가중�?�균가는 412�?�? �?��?�성분내 최고가�?� 노바스�?�정5mg�?� 418�?으로 �?�균보다 1.46%가 높�?� 것으로 확�?��??다. 메디파나뉴스

Animal welfare, advocacy among conference workshop topics  -  04 Feb 2009
A lawsuit against a veterinarian and a compounding pharmacy alleges two cats died after they ate amlodipine chew tabs with a higher-than-prescribed drug American Veterinary Medical Association,

Generics manufacturer pulls plug on nearly its entire product line  -  Jan 29, 2009
On the list of suspended drugs are preparations of amlodipine, diltiazem, isosorbide mononitrate, nitroglycerin, and propafenone along with potassium TheHeart.Org,

Angiotensin II receptor blockers  -  Jan 21, 2009
...[1] You can get valsartan combined with a drug called amlodipine. Amlodipine is a type of drug called a calcium channel blocker. guardian.co.uk,

New Data on Aliskiren Provoke Debate  -  Jan 20, 2009
From week 12, the calcium channel blocker amlodipine 5 mg was added and titrated to 10 mg from week 18 for patients whose BP remained uncontrolled. Medscape

Ipsen announces the signature of a co-promotion agreement with ...  -  Jan 28, 2009
In practice, preferred following associations are recommended: The fixed combination of valsartan/amlodipine enables the treatment of hypertension in WELT ONLINE,

What's the evidence for nitrates?  -  Jan 21, 2009
Hall R, Chong C. A double-blind parallel group study of amlodipine versus long acting nitrate in the management of elderly patients with stable angina. guardian.co.uk,

(Ξένη δημοσίευση)-Α�?ΑΚΟΙ�?ΩΣΗ ΤΥΠΟΥ-PRN-Blood Pressure Goal Missed ...  -  Jan 22, 2009
To address the current critical situation key respond to treatment with 8 weeks of amlodipine. At randomization almost 75% in as little as 8 weeks after Αθηναικο Π�?ακτο�?είο Ειδήσεων,

Research and Markets: Novartis: Performance - Products - Pipeline ...  -  Feb 3, 2009
Exforge (valsartan+amlodipine) and Lucentis (ranibizumab), should offset the decline in sales of a number of Novartis' strategic products. Trading Markets (press release),

What treatments work for Raynaud's disease?  -  Jan 21, 2009
One study found that amlodipine reduced the number of attacks in people with Raynaud's disease, but the study was very small. [5] More studies are needed to guardian.co.uk,

Drug Making’s Move Abroad Stirs Concerns  -  Jan 19, 2009
The same is true for dozens of other crucial medicines, including the popular allergy medicine prednisone; metformin, for diabetes; and amlodipine, New York Times,

Pfizer's acquisition of Wyeth brings scale but will fail to ...  -  Jan 28, 2009
The hypertension therapy Norvasc (amlodipine) lost patent exclusivity in 2007, as did the Zyrtec (cetirizine) franchise, indicated for allergic rhinitis. Trading Markets (press release),

Pregnancy can give rise to diabetes  -  Jan 24, 2009
Norvasc (amlodipine) is a different class of blood pressure medicine. It can cause ankle swelling. Ten milligrams is considered a maximum dose. South Coast Today,

Calcium channel blockers  -  Jan 21, 2009
...[1] You can get amlodipine combined with a drug called valsartan. Valsartan is a type of drug called an angiotensin II receptor blocker. guardian.co.uk,

What treatments work for heart failure?  -  Jan 21, 2009
These drugs stop calcium entering the cells of the heart muscle. This makes your heart beat less strongly. One example is amlodipine (brand name Istin). guardian.co.uk,

What's the evidence for beta-blockers?  -  Jan 21, 2009
Singh S. Long term double blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. Clinical Cardiology. guardian.co.uk,

Is America relying too much on medicine from abroad?  -  Jan 23, 2009
...crucial medicines, such as prednisone (used to treat autoimmune and inflammatory diseases); metformin (diabetes); and amlodipine (high blood pressure). Consumer reports

Novartis earnings rise but performance disappoints investors  -  Jan 28, 2009
As for Novartis’ newer products, the cardiovascular drug Exforge (amlodipine plus valsartan) brought in $118 million, up 131%, while Exjade (deferasirox), Pharma Times,

Ranbaxy Lab swings to loss for FY 08  -  Jan 22, 2009
Ranbaxy will have a license to sell generic versions of Atorvastatin and the fixed-dose combination of Atorvastatin-Amlodipine Besylate in the United States Myiris.com,

Ipsen announces the signature of a co-promotion agreement  -  Jan 29, 2009
...widely-prescribed and widely studied antihypertensive drugs: valsartan, a sartan issued from Novartis research, and amlodipine, a calcium inhibitor. Euronext (persbericht),

Can Racial, Awareness, Measurement, Genetic, and Possibly ...  -  Jan 12, 2009
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide Medscape

Novartis increases dividend by 25% based on strong 2008 results ...  -  Jan 27, 2009
Exforge (USD 406 million), a single-pill combination of the angiotensin receptor blocker Diovan (valsartan) with the calcium channel blocker amlodipine, Trading Markets (press release),

CAFE-LLA study presents principal results  -  Jan 27, 2009
...can be reduced significantly by combining a cholesterol-reducing drug, Atorvastatin calcium, with a blood pressure-lowering drug, Amlodipine Besylate. Newsdesk (pressmeddelande),

Accord de co-promotion en France entre Novartis Pharma et Ipsen ...  -  Feb 2, 2009
Exforge® associe en un comprimé deux molécules largement étudiées et parmi les plus prescrites dans le monde, le valsartan et l'amlodipine, Gazette du Laboratoire,

B’nai B’rith entregó fármacos contra la hipertensión arterial  -  Jan 17, 2009
En la ocasión fueron entregados al MSP 3.125 frascos de Trandolapril Tab 2mg, 4.668 frascos de Trandolapril Tab 4mg, 5184 frascos de Amlodipine Tab 5mg, ABC Color,

Donan medicamentos por cincuenta millones de dólares  -  Jan 23, 2009
27 envases de Amlodipine Besylate por 5 mg comprimidos por 90 cada envase, total 2430 comprimidos. 107 envases de Ramipril de 1,25 mg por 30 comprimidos, TerritorioDigital.com,

RPT/Novartis/Ipsen: accord de co-promotion d'Exforge (hypertension)  -  Jan 28, 2009
...contre l'hypertension, selon Ipsen. Exforge, commercialisé depuis août 2007, associe dans un seul comprimé deux molécules, le valsartan et l'amlodipine. Romandie.com,

Ipsen engrange 5,5 % de croissance en 2008 et un nouvel accord ...  -  Jan 29, 2009
...en France d'Exforge, antihypertenseur développé par le géant suisse, qui associe les deux molécules valsartan et amlodipine dans un seul comprimé. L'Usine Nouvelle,

Deux tiers des patients n'atteignent pas l'objectif de pression ...  -  Jan 22, 2009
à-dire incapables d'atteindre l'objectif de PA avec une monothérapie à base d'amlodipine. Les principaux résultats montrent que la prise de SEVIKAR(R) s'est PR Newswire UK (press release),

광�?�제약, CCB계열 고혈압 치료제 ‘�?스암로딕스 정’ 출시  -  Jan 11, 2009
...‘�?스암로딕스정’�?� 3세대 Dihydropyridine계 CCB계열�?� 고혈압치료제로서 기존�?� 베실산 암로디핀�?� �?�성질체�?� R-암로디핀�?� 떼어낸 제품으로, Amlodipine besylate YTN,

항고혈압제 ‘로우디핀정’...심근경색과 뇌졸중까지 잡는다  -  Jan 9, 2009
...최연�?� 기�? 드림파마(대표�?�사 조창호)가 지난해 10월 발매한 암로디핀 베실레�?�트(Amlodipine besylate 5mg) 계열�?� 고혈압치료제 ‘로우디핀정’�?� 올해 주력품목으로 헬스코리아뉴스,

광�?�제약, 순환기계 약물 대�?� 강화  -  Jan 11, 2009
...�?스암로딕스정�?� 기존�?� ‘암로디핀 베실레�?�트Amlodipine besylate’�?� 2분�?� 1 용량으로�?� 기존 성분과 �?�등 �?��?�?� 작용시간 �? 혈압강화 효과를 나타낸다고 광�?� 헬스코리아뉴스,

Novartis augmente son dividende de 25% -6-  -  Jan 27, 2009
Exforge (USD 406 millions), une seule pilule associant Diovan (valsartan), un inhibiteur des récepteurs de l'angiotensine et l'amlodipine, inhibiteur des Ad-Hoc-News (Pressemitteilung),

Brand Names/Synonyms:
Amlodipine is also known by the following brand names and/or synonymsAMLODIPINE BESYLATE, 99%; Amlocard; Amlodipine; Amlodipine Benzenesulfonate; Amlodipine Besilate; Amlodipine Besylate; Amlodipine Free Base; Amlodipino [Spanish]; Amlodipinum [Latin]; Amlodis; Amvaz; CHEMBANK1767; Coroval; Lipinox; Lotrel; Norvasc

Drug Category:
Amlodipine is categorized under the following by the FDA: Vasodilator Agents; Antianginal; Antihypertensive Agents; Calcium Channel Blockers; ATC:C08CA01

Dosage Forms:
white tablets equivalent to 2.5, 5 and 10 mg

Absorption:
Amlodipine is slowly and almost completely absorbed from the gastrointestinal tract.

Interactions:
-->Interactions for Amlodipine:

In vitro data indicate that NORVASC has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin.

Effect of other agents on NORVASC.

CIMETIDINE: Co-administration of NORVASC with cimetidine did not alter the pharmacokinetics of NORVASC.

GRAPEFRUIT JUICE: Co-administration of 240 mL of grapefruit juice with a single oral dose of amlodipine 10 mg in 20 healthy volunteers had no significant effect on the pharmacokinetics of amlodipine.

MAALOX (antacid): Co-administration of the antacid Maalox with a single dose of NORVASC had no significant effect on the pharmacokinetics of NORVASC.

SILDENAFIL: A single 100 mg dose of sildenafil (ViagraÒ) in subjects with essential hypertension had no effect on the pharmacokinetic parameters of NORVASC. When NORVASC and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect.

Effect of NORVASC on other agents.

ATORVASTATIN: Co-administration of multiple 10 mg doses of NORVASC with 80 mg of atorvastatin resulted in no significant change in the steady state pharmacokinetic parameters of atorvastatin.

DIGOXIN: Co-administration of NORVASC with digoxin did not change serum digoxin levels or digoxin renal clearance in normal volunteers.

ETHANOL (alcohol): Single and multiple 10 mg doses of NORVASC had no significant effect on the pharmacokinetics of ethanol.

WARFARIN: Co-administration of NORVASC with warfarin did not change the warfarin prothrombin response time.

In clinical trials, NORVASC has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs.

Drug/Laboratory Test Interactions: None known.

Chemical IUPAC Name:
methylethyl2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate

:

Web health.mongabay.com/health

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.